Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants

NCT02477995 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

NETWORK

Sponsor class

Conditions

Pertussis

Interventions

BIOLOGICAL: DTaP Vaccine A
BIOLOGICAL: DTaP Vaccine B

Sponsor

Jiangsu Province Centers for Disease Control and Prevention